Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-09-050052
Filing Date
2009-09-25
Accepted
2009-09-25 16:14:32
Documents
1
Group Members
FROST GAMMA INVESTMENTS TRUST

Document Format Files

Seq Description Document Type Size
1 v161262_sc13da.htm SC 13D/A 111195
  Complete submission text file 0001144204-09-050052.txt   113135
Mailing Address 4400 BISCAYNE BLVD MIAMI FL 33137-3227
Business Address
FROST PHILLIP MD ET AL (Filed by) CIK: 0000898860 (see all company filings)

Type: SC 13D/A

Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Subject) CIK: 0001006281 (see all company filings)

EIN.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-50118 | Film No.: 091087806
SIC: 2836 Biological Products, (No Diagnostic Substances)